Back
Cardinal Health 10K Form
Sell
43
CAH
Cardinal Health
Last Price:
103.38
Seasonality Move:
3.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-02-01 | 10Q | CAH/Cardinal Health Quarterly |
2023-11-03 | 10Q | CAH/Cardinal Health Quarterly |
2023-08-15 | 10K | CAH/Cardinal Health Annual |
2023-05-04 | 10Q | CAH/Cardinal Health Quarterly |
2023-02-02 | 10Q | CAH/Cardinal Health Quarterly |
2022-11-04 | 10Q | CAH/Cardinal Health Quarterly |
Receive CAH News And Ratings
See the #1 stock for the next 7 days that we like better than CAH
CAH Financial Statistics
Sales & Book Value
Annual Sales: | $205.01B |
---|---|
Cash Flow: | $1.08B |
Price / Cash Flow: | 7.63 |
Annual Sales: | $-14.17 |
Price / Book: | 0 |
Profitability
EPS (TTM): | 2.54000 |
---|---|
Net Income (TTM): | $639M |
Gross Margin: | $6.89B |
Return on Equity: | 0% |
Return on Assets: | 1.44% |
Cardinal Health Earnings Forecast
Key Cardinal Health Financial Ratios
- The Gross Profit Margin over the past 40 years for CAH is 3.36%.
- The Selling, General & Administrative Expenses for CAH have been equal to 2.36% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 35.63% of Operating Income.
- The Net Earning history of CAH is 0.13% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 25 years.
Cardinal Health Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | CAH |
CUSIP: | 14149Y |
Website: | cardinalhealth.com |
Debt
Debt-to-Equity Ratio: | -1.37 |
---|---|
Current Ratio: | 0.98 |
Quick Ratio: | 0.43 |
Price-to-Earnings
Trailing P/E Ratio: | 103.37 |
---|---|
Forward P/E Ratio: | 13.1 |
CAH Technical Analysis vs Fundamental Analysis
Sell
43
Cardinal Health (CAH)
is a Sell
Is Cardinal Health a Buy or a Sell?
-
Cardinal Health stock is rated a Sell
The current Cardinal Health [CAH] share price is $103.37. The Score for CAH is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.